BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dai F, Wu Y, Lu Y, An C, Zheng X, Dai L, Guo Y, Zhang L, Li H, Xu W, Gao W. Crosstalk between RNA m6A Modification and Non-coding RNA Contributes to Cancer Growth and Progression. Mol Ther Nucleic Acids 2020;22:62-71. [PMID: 32911345 DOI: 10.1016/j.omtn.2020.08.004] [Cited by in Crossref: 16] [Cited by in F6Publishing: 35] [Article Influence: 8.0] [Reference Citation Analysis]
Number Citing Articles
1 Geng R, Chen T, Zhong Z, Ni S, Bai J, Liu J. The m6A-Related Long Noncoding RNA Signature Predicts Prognosis and Indicates Tumor Immune Infiltration in Ovarian Cancer. Cancers (Basel) 2022;14:4056. [PMID: 36011053 DOI: 10.3390/cancers14164056] [Reference Citation Analysis]
2 Zhang Y, Li L, Chu F, Xiao X, Zhang L, Li K, Wu H. Identification and Validation of an m6A-Related LncRNA Signature to Predict Progression-Free Survival in Colorectal Cancer. Pathol Oncol Res 2022;28:1610536. [DOI: 10.3389/pore.2022.1610536] [Reference Citation Analysis]
3 Huang J, Song J, Li X, Liu S, Huang W, Shen Z, Cheng Y, Kou S, Gao Z, Tian Y, Hu J. Analysis and prognostic significance of tumour immune infiltrates and immune microenvironment of m6A-related lncRNAs in patients with gastric cancer. BMC Med Genomics 2022;15:164. [PMID: 35879790 DOI: 10.1186/s12920-022-01318-5] [Reference Citation Analysis]
4 Zhang W, Wu W, Meng Q, Yang L, Yuan J, Tian Z, Ding R, Zhang X, Wang J, Tao K. Research Progress on Long Noncoding RNAs and N6-Methyladenosine in Hepatocellular Carcinoma. Front Oncol 2022;12:907399. [DOI: 10.3389/fonc.2022.907399] [Reference Citation Analysis]
5 Ding Y, Wang T, Feng Y, Ding X, Li X, Huang Z, Jia Z, Wang J, Yang J. Integrated Analyses Reveal Potential Functional N6-Methyladenosine-Related Long Noncoding RNAs in Adrenocortical Adenocarcinoma. Front Cell Dev Biol 2022;10:851748. [PMID: 35669515 DOI: 10.3389/fcell.2022.851748] [Reference Citation Analysis]
6 Zhang W, Zhang Q, Xie Z, Che L, Xia T, Cai X, Liu S. N6-Methyladenosine-Related Long Non-Coding RNAs Are Identified as a Potential Prognostic Biomarker for Lung Squamous Cell Carcinoma and Validated by Real-Time PCR. Front Genet 2022;13:839957. [DOI: 10.3389/fgene.2022.839957] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Peng L, Pan B, Zhang X, Wang Z, Qiu J, Wang X, Tang N. Lipopolysaccharide facilitates immune escape of hepatocellular carcinoma cells via m6A modification of lncRNA MIR155HG to upregulate PD-L1 expression. Cell Biol Toxicol 2022. [PMID: 35438468 DOI: 10.1007/s10565-022-09718-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Zhang Z, Wang F, Zhang J, Zhan W, Zhang G, Li C, Zhang T, Yuan Q, Chen J, Guo M, Xu H, Yu F, Wang H, Wang X, Kong W. An m6A-Related lncRNA Signature Predicts the Prognosis of Hepatocellular Carcinoma. Front Pharmacol 2022;13:854851. [PMID: 35431958 DOI: 10.3389/fphar.2022.854851] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Zhuo R, Xu M, Wang X, Zhou B, Wu X, Leone V, Chang EB, Zhong X. The regulatory role of N6 -methyladenosine modification in the interaction between host and microbes. Wiley Interdiscip Rev RNA 2022;:e1725. [PMID: 35301791 DOI: 10.1002/wrna.1725] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
10 Huang X, Guo H, Wang L, Yang L, Shao Z, Zhang W. Recent advances in crosstalk between N6-methyladenosine (m6A) modification and circular RNAs in cancer. Mol Ther Nucleic Acids 2022;27:947-55. [PMID: 35211355 DOI: 10.1016/j.omtn.2022.01.013] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
11 Yuan B, Liu W, Huo M, Zhang J, Yang Y, Gao T, Yin X, Yang T, Teng X, Huang W, Yu H. The hub ten gene-based risk score system using RNA m6A methylation regulator features and tumor immune microenvironment in breast cancer. Breast Cancer 2022. [PMID: 35174450 DOI: 10.1007/s12282-022-01341-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Wu H, Ding X, Hu X, Zhao Q, Chen Q, Sun T, Li Y, Guo H, Li M, Gao Z, Yao W, Zhao L, Li K, Wei M. LINC01021 maintains tumorigenicity by enhancing N6-methyladenosine reader IMP2 dependent stabilization of MSX1 and JARID2: implication in colorectal cancer. Oncogene 2022. [PMID: 35173309 DOI: 10.1038/s41388-022-02189-x] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
13 Yang K, Wang F, Li K, Peng G, Yang H, Xu H, Xiang Y, Sun H. N6-methyladenosine Modification-Related Long Non-Coding RNAs are Potential Biomarkers for Predicting the Prognosis of Patients With Osteosarcoma. Technol Cancer Res Treat 2022;21:15330338221085354. [PMID: 35422168 DOI: 10.1177/15330338221085354] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
14 Lu M, Zhan H, Liu B, Li D, Li W, Chen X, Zhou X. N6-methyladenosine-related non-coding RNAs are potential prognostic and immunotherapeutic responsiveness biomarkers for bladder cancer. EPMA J 2021;12:589-604. [PMID: 34950253 DOI: 10.1007/s13167-021-00259-w] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
15 Zhang Y, Hua X, Shi H, Zhang L, Xiao H, Liang C. Systematic analyses of the role of prognostic and immunological EIF3A, a reader protein, in clear cell renal cell carcinoma. Cancer Cell Int 2021;21:680. [PMID: 34923969 DOI: 10.1186/s12935-021-02364-2] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
16 Wang E, Li Y, Ming R, Wei J, Du P, Zhou P, Zong S, Xiao H. The Prognostic Value and Immune Landscapes of a m6A/m5C/m1A-Related LncRNAs Signature in Head and Neck Squamous Cell Carcinoma. Front Cell Dev Biol 2021;9:718974. [PMID: 34917609 DOI: 10.3389/fcell.2021.718974] [Cited by in F6Publishing: 7] [Reference Citation Analysis]
17 Guo X, Piao H. Research Progress of circRNAs in Glioblastoma. Front Cell Dev Biol 2021;9:791892. [PMID: 34881248 DOI: 10.3389/fcell.2021.791892] [Reference Citation Analysis]
18 Lv W, Wang Y, Zhao C, Tan Y, Xiong M, Yi Y, He X, Ren Y, Wu Y, Zhang Q. Identification and Validation of m6A-Related lncRNA Signature as Potential Predictive Biomarkers in Breast Cancer. Front Oncol 2021;11:745719. [PMID: 34722303 DOI: 10.3389/fonc.2021.745719] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
19 Liu H, Qin S, Liu C, Jiang L, Li C, Yang J, Zhang S, Yan Z, Liu X, Yang J, Sun X. m6A reader IGF2BP2-stabilized CASC9 accelerates glioblastoma aerobic glycolysis by enhancing HK2 mRNA stability. Cell Death Discov 2021;7:292. [PMID: 34645788 DOI: 10.1038/s41420-021-00674-y] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
20 Zhang S, Long F, Lin H, Wang X, Jiang G, Wang T. Regulatory roles of phytochemicals on circular RNAs in cancer and other chronic diseases. Pharmacol Res 2021;174:105936. [PMID: 34653635 DOI: 10.1016/j.phrs.2021.105936] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
21 Yu X, Dong P, Yan Y, Liu F, Wang H, Lv Y, Song M, Yao Q, Hu S. Identification of N6-Methyladenosine-Associated Long Non-coding RNAs for Immunotherapeutic Response and Prognosis in Patients With Pancreatic Cancer. Front Cell Dev Biol 2021;9:748442. [PMID: 34621754 DOI: 10.3389/fcell.2021.748442] [Cited by in F6Publishing: 3] [Reference Citation Analysis]
22 Sun M, Xie M, Zhang T, Wang Y, Huang W, Xia L. m6A Methylation Modification Patterns and Tumor Microenvironment Infiltration Characterization in Pancreatic Cancer. Front Immunol 2021;12:739768. [PMID: 34616403 DOI: 10.3389/fimmu.2021.739768] [Cited by in F6Publishing: 4] [Reference Citation Analysis]
23 Zhang H, Qin C, An C, Zheng X, Wen S, Chen W, Liu X, Lv Z, Yang P, Xu W, Gao W, Wu Y. Application of the CRISPR/Cas9-based gene editing technique in basic research, diagnosis, and therapy of cancer. Mol Cancer 2021;20:126. [PMID: 34598686 DOI: 10.1186/s12943-021-01431-6] [Cited by in F6Publishing: 13] [Reference Citation Analysis]
24 Ji F, Lu Y, Chen S, Lin X, Yu Y, Zhu Y, Luo X. m6A methyltransferase METTL3-mediated lncRNA FOXD2-AS1 promotes the tumorigenesis of cervical cancer. Mol Ther Oncolytics 2021;22:574-81. [PMID: 34589576 DOI: 10.1016/j.omto.2021.07.004] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
25 Wang Y, Li N, Tian D, Zhou CW, Wang YH, Yang C, Zeng MS. Analysis of m6A-Related lncRNAs for Prognosis Value and Response to Immune Checkpoint Inhibitors Therapy in Hepatocellular Carcinoma. Cancer Manag Res 2021;13:6451-71. [PMID: 34429653 DOI: 10.2147/CMAR.S322179] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
26 Ma YS, Cao YF, Liu JB, Li W, Deng J, Yang XL, Xin R, Shi Y, Zhang DD, Lv ZW, Fu D. The power and the promise of circRNAs for cancer precision medicine with functional diagnostics and prognostic prediction. Carcinogenesis 2021:bgab071. [PMID: 34313732 DOI: 10.1093/carcin/bgab071] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
27 Zhang P, Liu G, Lu L. N6-Methylandenosine-Related lncRNA Signature Is a Novel Biomarkers of Prognosis and Immune Response in Colon Adenocarcinoma Patients. Front Cell Dev Biol 2021;9:703629. [PMID: 34336856 DOI: 10.3389/fcell.2021.703629] [Cited by in F6Publishing: 5] [Reference Citation Analysis]
28 Tang J, Han T, Tong W, Zhao J, Wang W. N6-methyladenosine (m6A) methyltransferase KIAA1429 accelerates the gefitinib resistance of non-small-cell lung cancer. Cell Death Discov 2021;7:108. [PMID: 34001850 DOI: 10.1038/s41420-021-00488-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
29 Rong D, Sun G, Wu F, Cheng Y, Sun G, Jiang W, Li X, Zhong Y, Wu L, Zhang C, Tang W, Wang X. Epigenetics: Roles and therapeutic implications of non-coding RNA modifications in human cancers. Mol Ther Nucleic Acids 2021;25:67-82. [PMID: 34188972 DOI: 10.1016/j.omtn.2021.04.021] [Cited by in Crossref: 1] [Cited by in F6Publishing: 18] [Article Influence: 1.0] [Reference Citation Analysis]
30 Wu P, Fang X, Liu Y, Tang Y, Wang W, Li X, Fan Y. N6-methyladenosine modification of circCUX1 confers radioresistance of hypopharyngeal squamous cell carcinoma through caspase1 pathway. Cell Death Dis 2021;12:298. [PMID: 33741902 DOI: 10.1038/s41419-021-03558-2] [Cited by in Crossref: 3] [Cited by in F6Publishing: 28] [Article Influence: 3.0] [Reference Citation Analysis]
31 Geng X, Zhang Y, Zeng Z, Zhu Z, Wang H, Yu W, Li Q. Molecular Characteristics, Prognostic Value, and Immune Characteristics of m6A Regulators Identified in Head and Neck Squamous Cell Carcinoma. Front Oncol 2021;11:629718. [PMID: 33816266 DOI: 10.3389/fonc.2021.629718] [Cited by in Crossref: 1] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
32 Li L, Miao H, Chang Y, Yao H, Zhao Y, Wu F, Song X. Multidimensional crosstalk between RNA-binding proteins and noncoding RNAs in cancer biology. Semin Cancer Biol 2021:S1044-579X(21)00057-2. [PMID: 33722631 DOI: 10.1016/j.semcancer.2021.03.007] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Zhao H, Xu Y, Xie Y, Zhang L, Gao M, Li S, Wang F. m6A Regulators Is Differently Expressed and Correlated With Immune Response of Esophageal Cancer. Front Cell Dev Biol 2021;9:650023. [PMID: 33748145 DOI: 10.3389/fcell.2021.650023] [Cited by in Crossref: 3] [Cited by in F6Publishing: 24] [Article Influence: 3.0] [Reference Citation Analysis]
34 Lv W, Liu S, Zhang Q, Hu W, Wu Y, Ren Y. Circular RNA CircCOL5A1 Sponges the MiR-7-5p/Epac1 Axis to Promote the Progression of Keloids Through Regulating PI3K/Akt Signaling Pathway. Front Cell Dev Biol 2021;9:626027. [PMID: 33553184 DOI: 10.3389/fcell.2021.626027] [Cited by in F6Publishing: 6] [Reference Citation Analysis]
35 Geng X, Zhang Y, Li Q, Xi W, Yu W, Shi L, Lin X, Sun S, Wang H. Screening and functional prediction of differentially expressed circular RNAs in human glioma of different grades. Aging (Albany NY) 2020;13:1989-2014. [PMID: 33323543 DOI: 10.18632/aging.202192] [Cited by in Crossref: 2] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]